)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Jagsonpal Pharmaceuticals (JAGSNPHARM) investor relations material
Jagsonpal Pharmaceuticals Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary28 Jul, 2025
Executive summary
Revenue grew 23.1% year-over-year to INR 75.6 crores (Rs. 756 Mn), with net profit more than doubling to INR 10.8 crores (Rs. 108 Mn), driven by strong brand equity and disciplined execution.
Free cash flow increased by INR 15.3 crores (Rs. 153 Mn), ending the quarter with INR 161 crores (Rs. 1,609 Mn) in cash, supporting future growth and acquisitions.
Maintained leadership in Gynae CVM, ranking #7, and reinforced presence in key therapy areas.
Unaudited financial results for the quarter ended June 30, 2025, were approved by the Board on July 26, 2025.
Termination of CFO for misconduct, with board and finance team commended for swift action; recruitment for new CFO ongoing.
Financial highlights
Revenue from operations rose to INR 75.6 crores (Rs. 756 Mn), up 23.1% year-over-year; operating EBITDA increased 24% to INR 15.7 crores (Rs. 157 Mn), with margins at 20.8%.
Gross margin improved by 80 bps to 64.4%; PAT margin expanded to 14.3%.
Cash balance stood at INR 161 crores (Rs. 1,609 Mn), up 107.3% year-over-year.
Basic EPS for Q1 FY26 was INR 1.60, compared to INR 0.78 in Q1 FY25.
Top 15 brands account for two-thirds of business; ranked top 5 in 14 of these, and number 1 in several.
Outlook and guidance
Maintains 15% annual revenue growth guidance, with 9-10% organic and remainder from Yash Pharma acquisition annualization.
EBITDA margin guidance of 100-150 bps expansion for the year, with margin improvement expected from Q2.
ROE expected to remain in the 18-19% range over the next two years.
Plans to launch 4-6 new products annually and pursue strategic inorganic opportunities.
A final dividend of INR 2.5 per equity share (INR 166 million total) for FY25 was recommended, pending AGM approval.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Jagsonpal Pharmaceuticals earnings date
Q2 25/2622 Oct, 2025
Next Jagsonpal Pharmaceuticals earnings date
Q2 25/2622 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Jagsonpal Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of branded generic formulations. The company offers a range of dosage forms including tablets, capsules, syrups, and injectables across therapeutic segments such as gynecology, orthopedics, dermatology, and general medicine. It serves domestic and international markets through an established distribution network and field force. The company is headquartered in New Delhi, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage